SCHEMBL29363239

SCHEMBL29363239

O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 16/20 1.00
IRAK1 P51617 3/20 1.00
MTOR P42345 1/20 1.00
DYRK3 O43781 1/20 0.72
ROCK2 O75116 1/20 0.72
RPS6KA5 O75582 1/20 0.72
PRKD3 O94806 1/20 0.72
MAP4K4 O95819 1/20 0.72
CDK1 P06493 1/20 0.72
PHKG2 P15735 1/20 0.72
MARK3 P27448 1/20 0.72
CSNK1A1 P48729 1/20 0.72
CSNK1D P48730 1/20 0.72
CLK2 P49760 1/20 0.72
GSK3B P49841 1/20 0.72
NEK4 P51957 1/20 0.72
CSNK1G2 P78368 1/20 0.72
ITK Q08881 1/20 0.72
MAP4K2 Q12851 1/20 0.72
DYRK1A Q13627 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3600534 1.00 IRAK4 (1.00) IRAK4IRAK1MTORDYRK3ROCK2
SCHEMBL175464 0.91 IRAK4 (0.82) IRAK4IRAK1MTORDYRK3ROCK2
SCHEMBL3604209 0.89 IRAK4 (0.79) IRAK4IRAK1MTORDYRK3ROCK2
SCHEMBL25956628 0.86 IRAK4 (1.00) IRAK4IRAK1MTORDYRK3ROCK2
SCHEMBL16261073 0.85 MTOR (0.74) IRAK4IRAK1MTORKDM4ENPSR1
SCHEMBL29827291 0.85 IRAK4 (0.89) IRAK4IRAK1MTORDYRK3ROCK2
SCHEMBL25956620 0.85 IRAK4 (0.89) IRAK4IRAK1MTORDYRK3ROCK2
SCHEMBL18427725 0.84 IRAK4 (1.00) IRAK4IRAK1MTORDYRK3ROCK2
SCHEMBL25956637 0.84 IRAK4 (1.00) IRAK4IRAK1MTORDYRK3ROCK2
SCHEMBL13500540 0.83 OPRK1 (0.86) IRAK4IRAK1MTORKDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4185279-A1 TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS Secura Bio, Inc. (US) 2023-05-31 EP disclosed
CN-105682658-B Cancer therapy using PI3 kinase subtype modulators 无限药品公司 2022-04-05 CN disclosed
WO-2022019920-A1 TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS VERASTEM, INC. (US) 2022-01-27 WO disclosed